We are live on !
Find out more
Melqart Asset Management Portfolio holdings
AUM
$1.05B
Turnover
52.73%
1-Year Est. Return
111.55%
This Fund
S&P 500
This Quarter Est. Return
+30.12%
1 Year Est. Return
+111.55%
3 Year Est. Return
+250.05%
5 Year Est. Return
+392.95%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
+$36.7M
(+3.6%)
Cap. Flow
-$175M
Cap. Flow % of AUM
Cap. Flow %
-16.64%
Top 10 Holdings %
Top 10 Hldgs %
59.84%
Holding
55
New
14
Increased
11
Reduced
15
Closed
15
Avg Time Held
0.6
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$69.2M |
| 2 |
Abivax
ABVX
|
+$34.8M |
| 3 |
Penumbra
PEN
|
+$33.7M |
| 4 |
Norfolk Southern
NSC
|
+$25.3M |
| 5 |
Caesars Entertainment
CZR
|
+$18.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$61.9M |
| 2 |
Clearwater Analytics
CWAN
|
+$53.6M |
| 3 |
Kenvue
KVUE
|
+$43.2M |
| 4 |
Marvell Technology
MRVL
|
+$38.7M |
| 5 |
TSMC
TSM
|
+$29.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.97% |
| 2 | Technology | 19.78% |
| 3 | Communication Services | 18.94% |
| 4 | Industrials | 17.7% |
| 5 | Utilities | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
DELISTED
Warner Bros
WBD
| $122M | 11.63% |
4,583,750
+2,556,141
| +126% | +$69.2M |
2025 Q4
2 quarters
|
|
2
TXNM Energy Inc
TXNM
$6.43B
| $77.8M | 7.4% |
1,370,244
+319,297
| +30% | +$18.7M |
2025 Q3
3 quarters
|
|
|
3
Norfolk Southern
NSC
$77B
| $76.4M | 7.27% |
242,944
+82,096
| +51% | +$25.3M |
2025 Q4
2 quarters
|
|
4
DELISTED
Electronic Arts
EA
| $73M | 6.95% |
356,261
-13,588
| -4% | -$2.75M |
2025 Q4
2 quarters
|
|
5
Cytokinetics
CYTK
$8.76B
| $65.4M | 6.22% |
767,525
-76,424
| -9% | -$5.49M |
2024 Q1
9 quarters
|
|
|
6
Penumbra
PEN
$12.6B
| $58.6M | 5.58% |
185,734
+103,912
| +127% | +$33.7M |
2026 Q1
1 quarter
|
|
7
DELISTED
Chart Industries
GTLS
| $44.8M | 4.27% |
214,647
-50,589
| -19% | -$10.5M |
2025 Q4
2 quarters
|
|
|
8
Abivax
ABVX
$7.58B
| $40.9M | 3.9% |
+307,250
| New | +$34.8M |
2026 Q2
0 quarters
|
|
9
Global Payments
GPN
$25.6B
| $38.7M | 3.68% |
532,688
+103,407
| +24% | +$7.12M |
2025 Q4
2 quarters
|
|
10
AES
AES
$10.6B
| $30.8M | 2.93% |
2,103,152
+1,183,920
| +129% | +$17.2M |
2026 Q1
1 quarter
|
|
11
Advanced Micro Devices
AMD
$824B
| $27.3M | 2.6% |
46,971
-22,907
| -33% | -$9.39M |
2025 Q4
2 quarters
|
|
12
ASML
ASML
$604B
| $25.5M | 2.43% |
12,824
-6,046
| -32% | -$9.6M |
2026 Q1
1 quarter
|
|
13
NVIDIA
NVDA
$4.94T
| $24.9M | 2.37% |
124,402
-121,402
| -49% | -$25M |
2025 Q1
5 quarters
|
|
14
Indivior Pharmaceuticals
INDV
$4.17B
| $24M | 2.29% |
585,664
-98,656
| -14% | -$3.58M |
2026 Q1
1 quarter
|
|
15
Revolution Medicines
RVMD
$41B
| $22.7M | 2.16% |
121,308
-149,055
| -55% | -$21.8M |
2026 Q1
1 quarter
|
|
16
Unifirst Corp
UNF
$4.61B
| $22.4M | 2.14% |
84,865
+11,051
| +15% | +$2.89M |
2026 Q1
1 quarter
|
|
|
17
TSMC
TSM
$2.11T
| $20.5M | 1.95% |
42,903
-73,567
| -63% | -$29.9M |
2025 Q1
5 quarters
|
|
|
18
Caesars Entertainment
CZR
$5.93B
| $20.1M | 1.91% |
+665,410
| New | +$18.8M |
2026 Q2
0 quarters
|
|
19
Amazon
AMZN
$2.59T
| $16.2M | 1.55% |
+68,122
| New | +$17.1M |
2026 Q2
0 quarters
|
|
20
DELISTED
Apogee Therapeutics
APGE
| $15.6M | 1.48% |
+117,249
| New | +$10.6M |
2026 Q2
0 quarters
|
|
|
TWO
21
DELISTED
Two Harbors Investment
TWO
| $14.9M | 1.42% |
1,201,262
+824,292
| +219% | +$9.9M |
2026 Q1
1 quarter
|
|
|
22
Marvell Technology
MRVL
$177B
| $13.7M | 1.31% |
46,079
-192,825
| -81% | -$38.7M |
2021 Q2
20 quarters
|
|
23
Lam Research
LRCX
$299B
| $13.4M | 1.28% |
+30,961
| New | +$9.4M |
2026 Q2
0 quarters
|
|
|
24
Sandisk
SNDK
$166B
| $13.4M | 1.27% |
5,874
-43,346
| -88% | -$61.9M |
2025 Q3
3 quarters
|
|
25
Arista Networks
ANET
$213B
| $13.3M | 1.26% |
+78,123
| New | +$12.3M |
2026 Q2
0 quarters
|
|
Similar funds
Melqart Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Melqart Asset Management held 55 positions worth $1.05B, up 3.6% from $1.01B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Melqart Asset Management withdrew a net $175M in Q2 2026, closing 15 positions and reducing 15 holdings. Its most notable exit was Clearwater Analytics, an estimated $53.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 15% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Melqart Asset Management opened a new position in Abivax worth $40.9M.
- Melqart Asset Management's largest Q2 2026 buy was Abivax: 307,250 shares worth $40.9M.
- Melqart Asset Management added most to Warner Bros in Q2 2026, an estimated $69.2M increase.
- Melqart Asset Management's biggest Q2 2026 reduction was Sandisk, cutting an estimated $61.9M.
- Melqart Asset Management fully exited Clearwater Analytics in Q2 2026, selling an estimated $53.6M.
- Melqart Asset Management's ten largest holdings make up 60% of its $1.05B portfolio in Q2 2026.
- Melqart Asset Management opened 14 new positions and closed 15 in Q2 2026.
- Melqart Asset Management's portfolio value rose 3.6% quarter-over-quarter to $1.05B.
Based on Melqart Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.